AU Patent

AU776962B2 — Substituted 3-cyano-(1.7), (1.5), and (1.8)-naphthyridine inhibitors of tyrosine kinases

Assigned to Wyeth Holdings LLC · Expires 2004-09-30 · 22y expired

What this patent protects

Patent listed against Inrebic.

Drugs covered by this patent

Patent Metadata

Patent number
AU776962B2
Jurisdiction
AU
Classification
—
Expires
2004-09-30
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth Holdings LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.